Navigation Links
Terumo Medical Corp. reports first US implant in landmark study enrolling in US and Japan
Date:9/9/2010

Terumo Medical Corporation, a U.S.-based subsidiary of Terumo Corporation, today announced the first U.S. patient implant in the Occlusive/Stenotic Peripheral artery REvascularization StudY (OSPREY), which will evaluate the safety and efficacy of its MISAGO Peripheral Self-expanding Stent System for use in the superficial femoral artery (SFA). The procedure was performed at the Bradenton Cardiology Center in Bradenton, Florida.

A unique feature of the OSPREY clinical trial is that it will simultaneously enroll patients in the U.S. and Japan. Referred to as "Medical Device Collaborative Consultation and Review of Premarketing Applications" under the larger Harmonization by Doing (HBD) initiative, the OSPREY trial was selected as one of two projects to pilot this approach, which is intended to shorten the gap between product approvals in these two significant world healthcare markets. The pilot program is a cooperative effort led by the U.S. Food & Drug Administration, the MHLW-PMDA (Japan's regulatory bodies), Terumo Corporation based in Tokyo, Japan, and Terumo Medical Corporation, a U.S.-based subsidiary of Terumo Corporation.

"We are pleased to be the first U.S. center to kick off this exciting international trial to evaluate the safety and efficacy of the MISAGO Stent System for treating patients with peripheral artery disease," said Srinivas Iyengar, MD, primary operator and site Principal Investigator for the OSPREY trial. "This is a unique and exciting opportunity for myself and the Bradenton Cardiology Center to be a part of the first international initiative to streamline the regulatory process to facilitate future medical device approvals between countries."

In the U.S., OSPREY is a single-arm, multi-center, non-randomized prospective clinical trial for the treatment of atherosclerotic stenoses and occlusions of the SFA. In Japan, there are two arms of the study, 50 patients receiving the MISAGO Stent System and 50 pat
'/>"/>

Contact: Robert Murphy
rmurphy@storchmurphy.com
908-276-0777
The Storch Murphy Group
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Developments in nanobiotechnology at UCSB point to medical applications
2. Novartis awards 2010 Prizes for Immunology in recognition of outstanding contributions to immunology in medical research
3. Montana State University offers 6 new biomedical technologies for licensing
4. OSA launches new journal, Biomedical Optics Express
5. What the doctor prescribes: Customized medical-image databases
6. Scientists at University of Colorado Anschutz Medical Campus discover new fat cell
7. Symposium to explore broadening partnerships to spur medical advances for war injuries
8. ACP Medical Laboratory Evaluation program gains approval from CAP accreditation program
9. UCI receives prestigious federal research award to hasten medical advances
10. Biomedical scientist concerned about effects of oil spill on human health
11. CIMIT announces $3 million in medical research grants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... Inc. (NASDAQ: NXTD ) ("NXT-ID" or the "Company") announces ... pricing and making the Wocket generally available for $229 via ... of Marketing said, "We,ve extended the opportunity to take advantage ... To get your wocket at this special price, submit your ... June 1, you,ll receive a unique code that gives you ...
(Date:5/20/2015)... , May 20, 2015 ... ) has announced the addition of ... Global Iris Recognition Market"  report to ... ,This research service analyses trends in ... government and commercial sectors, globally. Despite ...
(Date:5/19/2015)... 19, 2015 Research ... addition of the  "Genetic Testing Market Outlook ... http://photos.prnewswire.com/prnh/20130307/600769) , ,A recent report, Genetic Testing ... of the current and future genetic testing ... their working principles and types are covered ...
Breaking Biology News(10 mins):NXT-ID, Inc Announces Retail Price For Wocket Smart Wallet And Extends Discounted Promotional Price Till End Of May 2NXT-ID, Inc Announces Retail Price For Wocket Smart Wallet And Extends Discounted Promotional Price Till End Of May 3Global Iris Recognition Market Report 2015 - 5-Year Opportunity Analysis 2Global Genetic Testing Market Outlook 2018 2
... already living in some humans that target and trap ... findings today at the 2005 American Society for Microbiology ... has its natural enemy, and HIV should not be ... the Department of Oral Biology, College of Dentistry, University ...
... A small trial testing the safety of an experimental ... the National Institutes of Health's (NIH) Clinical Center in ... in 15 healthy adult volunteers, was developed for human ... Allergy and Infectious Diseases' (NIAID) Vaccine Research Center (VRC), ...
... essential to one of the plant kingdom's key immune ... a protective zone of dead cells around the infection ... how the plants keep from killing themselves after they ... Now, in the May 20 issue of the journal ...
Cached Biology News:Friendly bacteria in humans may protect against HIV 2NIAID begins clinical trial of West Nile virus vaccine 2NIAID begins clinical trial of West Nile virus vaccine 3Plant Sacrifices Cells to Fight Invaders 2
(Date:5/28/2015)... Sunnyvale, Californiaa (PRWEB) May 28, 2015 ... on “ The Changing Landscape of EMR/EHR Clinical Data ... Annual Meeting taking place in Washington, DC on June ... the challenges of integrating EMR/EHR systems with EDC, and ... the opportunities brought by eSource and electronic health records/electronic ...
(Date:5/28/2015)... 2015 Global futurist and keynote ... ask his audiences if they are ready for ... solar cells, fuel cells, rapid health care diagnostic ... storage technology, driverless cars, artificial intelligence masquerading as ... online education. , While the majority of ...
(Date:5/28/2015)... (PRWEB) May 28, 2015 Dr. ... announced today that Roger L. Williams, MD, has ... NDA Partners Premier Experts are top tier consultants ... bring extraordinary value to the company’s clients. Premier ... to help clients successfully develop their medical products, ...
(Date:5/28/2015)... Clinerion, an eClinical technology ... the Alliance for Clinical Research Excellence and ... operating in the public interest and dedicated ... quality, safety, integrity and operational effectiveness in ... pleased to announce their partnership for accelerating ...
Breaking Biology Technology:Clinovo Presents at the DIA 2015 51st Annual Meeting in Washington, DC on June 14th-18th 2Futurist Jack Uldrich to Deliver 4 Keynote Addresses in June 2Former CEO and Chair of the Council of Experts at the USP, Roger L. Williams, MD, Joins NDA Partners as a Premier Expert Consultant 2Clinerion and ACRES Partner on Patient Recruitment and Risk-Based Quality Management 2Clinerion and ACRES Partner on Patient Recruitment and Risk-Based Quality Management 3
... U.S. troops blew up enemy bridges with explosives in World ... forces. , In modern times, patrollers use explosives at ski ... when skiers arrive. , Other than creating the desired effect ... the microscopic details and extreme states of matter found within ...
... Stock Exchange Symbol: MS, EDMONTON, Dec. 11 ... developer in the treatment of multiple sclerosis (MS), ... (DSMB) has,reviewed data from the Company,s on-going MAESTRO-03 ... the treatment of secondary progressive MS and,recommended that ...
... Aids Mass Spectrometer Analysis -, HOPKINTON, Mass., ... CALP ) today announced the availability of the,Zephyr ... Solid,Phase Extraction (SPE). With features including a 96-well ... SPE Workstation is,designed to increase efficiency and streamline ...
Cached Biology Technology:Explosives at the microscopic scale produce shocking results 2BioMS Medical's phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board 2Caliper Life Sciences Introduces Zephyr SPE Workstation to Improve Efficiency of Solid Phase Extraction 2
... Analyzer for superior sensitivity, mass accuracy, and resolving power., Specifications:, ... ion selection range: 150 - 4000 m/z, * Resolution: 14,000 (1400 ... * Dynamic range: 4 orders of magnitude ... ...
... M (OSM) is a pleiotropic cytokine produced ... sarcoma cells. OSM inhibits the growth of ... fibroblast, smooth muscle and Kaposis sarcoma cell ... low density lipoprotein receptor expression on hepatoma ...
... trinor Prostaglandin F2α isopropyl ester (15(R)-17-phenyl ... latanoprost-related isomer containing both a double ... (β) hydroxyl group at C-15. Similar ... ester is a potential impurity in ...
ACS Reagent Grade C 19 H 14 O 5 S Formula Weight: 354.38 PRODUCT SPECIFICATIONS Form: Rust/red crystalline powder Clarity of Solution: Passes test Visual Transition Interval: pH 6.8 - Yellow pH 8.2...
Biology Products: